Greenwave Technology Solutions (GWAV) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The annual meeting is scheduled for August 13, 2025, and will be held virtually, with voting available online, by phone, or by mail.
Stockholders will vote on nine key proposals, including director elections, auditor ratification, executive compensation, warrant issuances, preferred stock issuance, reverse stock split authority, and meeting adjournment.
As of July 17, 2025, there are 61,169,509 shares of Common Stock and 450,000 shares of Series A-1 Preferred Stock outstanding and entitled to vote.
Voting matters and shareholder proposals
Proposals include electing three directors, ratifying RBSM LLP as auditor, advisory votes on executive compensation and its frequency, approval of new and amended warrant issuances, ratification of Series A-1 Preferred Stock issuance, authority for reverse stock splits, and potential adjournment to solicit more proxies.
Board recommends voting “FOR” all proposals and a three-year frequency for say-on-pay votes.
Each proposal requires a majority of shares present or represented by proxy to pass.
Stockholder proposals for the 2026 meeting must be submitted between April 15 and May 15, 2026, or by March 26, 2026, for inclusion in proxy materials.
Board of directors and corporate governance
Board consists of three members: Danny Meeks (CEO/Chair), Cheryl Lanthorn, and Lisa Lucas-Burke.
Two directors are independent per Nasdaq and SEC standards.
Four standing committees: Audit, Compensation, Nominating and Corporate Governance, and Sustainability.
Board and committees held regular meetings in 2024; all committee members are independent.
Insider trading and compensation recovery policies are in place.
Latest events from Greenwave Technology Solutions
- Revenue grew 24.7% year-over-year, but going concern risks persist amid ongoing losses.GWAV
Q3 20256 Mar 2026 - Q2 2025 revenue rose 39.5% and net loss narrowed, but going concern risks persist.GWAV
Q2 20255 Feb 2026 - Registering 27M+ shares for resale, with proceeds from warrants aimed at expansion and tech upgrades.GWAV
Registration Filing16 Dec 2025 - Q2 revenue fell 16% and net loss widened to $43.8M amid higher costs and major non-cash charges.GWAV
Q2 202412 Dec 2025 - Board seeks approval for director elections, capital actions, and related party transactions.GWAV
Proxy Filing2 Dec 2025 - Shareholders to vote on bylaw, equity plan, and warrant issuance amendments at July 2024 meeting.GWAV
Proxy Filing2 Dec 2025 - Shareholders will vote on expanding equity awards, issuing warrants, and potential meeting adjournment.GWAV
Proxy Filing2 Dec 2025 - Shareholders to vote on equity plan expansion, warrant issuance, and meeting adjournment authorization.GWAV
Proxy Filing2 Dec 2025 - Key votes on quorum, equity plan, and warrant issuance will shape future governance and dilution.GWAV
Proxy Filing2 Dec 2025